References
- Modell B, Darlison M. Global epidemiology of haemoglobin disorders and derived service indicators. Bull World Health Organ. 2008;86(6):480–487.
- Pan HF, Long GF, Li Q, et al. Current status of thalassemia in minority populations in Guangxi, China. Clin Genet. 2007;71(5):419–426.
- Steinberg MH, Adams JG 3rd. Hemoglobin A2: origin, evolution, and aftermath. Blood. 1991;78(9):2165–2177.
- Giambona A, Passarello C, Renda D, et al. The significance of the Hemoglobin A2 value in screening for hemoglobinopathies. Clin Biochem. 2009;42(18):1786–1796.
- Mosca A, Paleari R, Ivaldi G, et al. The role of haemoglobin A2 testing in the diagnosis of thalassaemias and related haemoglobinopathies. J Clin Pathol. 2009;62(1):13–17.
- Danjou F, Zoledziewska M, Sidore C, et al. Genome-wide association analyses based on whole-genome sequencing in Sardinia provide insights into regulation of hemoglobin levels. Nat Genet. 2015;47(11):1264–1271.
- Liu D, Zhang X, Yu L, et al. KLF1 mutations are relatively more common in a thalassemia endemic region and ameliorate the severity of β-thalassemia. Blood. 2014;124(5):803–811.
- Galarneau G, Palmer CD, Sankaran VG, et al. Fine-mapping at three loci known to affect fetal hemoglobin levels explains additional genetic variation. Nat Genet. 2010;42(12):1049–1051.
- Menzel S, Garner C, Rooks H, et al. HbA2 levels in normal adults are influenced by two distinct genetic mechanisms. Br J Haematol. 2013;160(1):101–105.
- Griffin PJ, Sebastiani P, Edward H, et al. The genetics of Hemoglobin A2 regulation in sickle cell anemia. Am J Hematol. 2014;89(11):1019–1023.
- Borg J, Papadopoulos P, Georgitsi M, et al. Haploinsufficiency for the erythroid transcription factor KLF1 causes hereditary persistence of fetal hemoglobin. Nat Genet. 2010;42(9):801–805.
- Perseu L, Satta S, Moi P, et al. KLF1 gene mutations cause borderline HbA(2). Blood. 2011;118(16):4454–4458.
- Perkins A, Xu X, Higgs DR, et al. Kruppeling erythropoiesis: an unexpected broad spectrum of human red blood cell disorders due to KLF1 variants. Blood. 2016;127(15):1856–1862.
- Tallack MR, Perkins AC. Three fingers on the switch: Krüppel-like factor 1 regulation of γ-globin to β-globin gene switching. Curr Opin Hematol. 2013;20(3):193–200.
- Musallam KM, Sankaran VG, Cappellini MD, et al. Fetal hemoglobin levels and morbidity in untransfused patients with β-thalassemia intermedia. Blood. 2012;119(2):364–367.
- Platt OS, Brambilla DJ, Rosse WF, et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med. 1994;330(23):1639–1644.
- Raj T, Kuchroo M, Replogle JM, et al. Common risk alleles for inflammatory diseases are targets of recent positive selection. Am J Hum Genet. 2013;92(4):517–529.
- Voight BF, Kudaravalli S, Wen X, et al. A map of recent positive selection in the human genome. PLoS Biol. 2006;4(3):e72.
- Raj T, Shulman JM, Keenan BT, et al. Alzheimer disease susceptibility loci: evidence for a protein network under natural selection. Am J Hum Genet. 2012;90(4):720–726.
- Purcell S, Neale B, Todd-Brown K, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81(3):559–575.
- Barrett JC, Fry B, Maller J, et al. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21(2):263–265.
- Dahimene S, Alcolea S, Naud P, et al. The N-terminal juxtamembranous domain of KCNQ1 is critical for channel surface expression: implications in the Romano–Ward LQT1 syndrome. Circ Res. 2006;99(10):1076–1083.
- Cordeiro A, Neto AP, Carvalho F, et al. Relevance of genomic imprinting in intrauterine human growth expression of CDKN1C, H19, IGF2, KCNQ1 and PHLDA2 imprinted genes. J Assist Reprod Genet. 2014;31(10):1361–1368.
- Sankaran VG, Xu J, Ragoczy T, et al. Developmental and species-divergent globin switching are driven by BCL11A. Nature. 2009;460(7259):1093–1097.
- Zhu Y, Zhang W, Huo Z, et al. A novel locus for maternally inherited human gingival fibromatosis at chromosome 11p15. Hum Genet. 2007;121(1):113–123.
- Chen J, Yao ZX, Chen JS, et al. TGF-β/β2-spectrin/CTCF-regulated tumor suppression in human stem cell disorder Beckwith–Wiedemann syndrome. J Clin Invest. 2016;126(2):527–542.
- Kim KP, Thurston A, Mummery C, et al. Gene-specific vulnerability to imprinting variability in human embryonic stem cell lines. Genome Res. 2007;17(12):1731–1742.
- Venkatraman A, He XC, Thorvaldsen JL, et al. Maternal imprinting at the H19-Igf2 locus maintains adult haematopoietic stem cell quiescence. Nature. 2013;500(7462):345–349.
- Zou P, Yoshihara H, Hosokawa K, et al. p57(Kip2) and p27(Kip1) cooperate to maintain hematopoietic stem cell quiescence through interactions with Hsc70. Cell Stem Cell. 2011;9(3):247–261.
- Worster DT, Schmelzle T, Solimini NL, et al. Akt and ERK control the proliferative response of mammary epithelial cells to the growth factors IGF-1 and EGF through the cell cycle inhibitor p57Kip2. Sci Signal. 2012;5(214):ra19.
- Altinoz MA, Elmaci I, Ince B, et al. Hemoglobins, hemorphins, and 11p15.5 chromosomal region in cancer biology and immunity with special emphasis for brain tumors. J Neurol Surg A Cent Eur Neurosurg. 2016;77(3):247–257.
- Karlsson EK, Kwiatkowski DP, Sabeti PC. Natural selection and infectious disease in human populations. Nat Rev Genet. 2014;15(6):379–393.
- Imboden M, Swan H, Denjoy I, et al. Female predominance and transmission distortion in the long-QT syndrome. N Engl J Med. 2006;355(26):2744–2751.